Targeting the HMGB1-TLR4 Axis Alleviates Neuropathic Pain-Associated Cognitive Deficits.

Area of Science:

• Neuroscience
• Immunology
• Pain Research

Background:

• Chronic pain, particularly neuropathic pain, is linked to cognitive deficits, significantly impacting patient quality of life.
• Toll-like receptor 4 (TLR4) is involved in neuroinflammation and synaptic plasticity, but its role in neuropathic pain-related cognitive dysfunction is unclear.

Purpose of the Study:

• To investigate the role of Toll-like receptor 4 (TLR4) in cognitive deficits associated with chronic neuropathic pain.
• To elucidate the molecular mechanisms linking peripheral nerve injury to central nervous system dysfunction and cognitive impairment.

Main Methods:

• Utilized a chronic constriction injury (CCI) model in male mice to induce neuropathic pain.
• Assessed cognitive function, neuroinflammation, neuronal apoptosis, and hippocampal neuroplasticity in wild-type, TLR4-knockout, and neuron-specific TLR4-knockdown mice.
• Investigated the role of high-mobility group box 1 (HMGB1) and its interaction with TLR4 using molecular and pharmacological approaches.

Main Results:

• CCI induced upregulation of TLR4 in hippocampal neurons and elevated HMGB1 levels.
• TLR4-knockout and knockdown mice showed improved cognitive function, reduced neuroinflammation, and preserved neuroplasticity compared to controls.
• HMGB1 administration worsened cognitive function, while HMGB1 inhibition with glycyrrhizin ameliorated CCI-induced cognitive deficits by attenuating TLR4 activation.

Conclusions:

• The HMGB1/TLR4 signaling axis critically mediates cognitive deficits in chronic neuropathic pain.
• HMGB1 released after nerve injury activates hippocampal TLR4, leading to neuroinflammation, apoptosis, and synaptic dysfunction.
• Targeting the HMGB1/TLR4 pathway presents a promising therapeutic strategy for mitigating pain-associated cognitive dysfunction.